Y. Levy et al., EFFECTS OF INTERFERON-ALPHA AND INTERFERON-GAMMA ON B-CELL DIFFERENTIATION IN MACROGLOBULINEMIA, Leukemia & lymphoma, 23(3-4), 1996, pp. 347-351
We previously showed that clonal blood B cells from patients with macr
oglobulinemia spontaneously differentiate in vitro to plasma cells via
an IL-6 autocrine pathway. Here we investigate whether interferon-alp
ha or -gamma would interfere with B cell differentiation either in pat
ients with IgM gammopathy of undetermined significance (IgM-MGUS) or W
aldenstrom's macroglobulinemia (WM). A 65% inhibition of in vitro B ce
ll differentiation was noted in 8 of 10 patients in the presence of ei
ther interferon -alpha or -gamma. Cells from 4 patients (3 IgM-MGUS an
d 1 WM) were susceptible to both types of interferon while B cell diff
erentiation from 4 patients (3 IgM-MGUS and 1 WM) was inhibited only b
y one type of interferon. During in vitro culture, IL6 synthesis was u
naffected by the presence of interferon alpha or gamma in the 8 cases
studied. Likewise, no modulation of the constitutive B cell IL6-R expr
ession from 6 patients studied (4 WM and 2 IgM-MGUS) was observed. The
se data indicate that interferons did not modify the differentiation o
f B cells in macroglobulinemia via modulation of the IL6-IL6-R pathway
. This is in contrast with the mode of action of interferons in other
lymphoid malignancies such as multiple myeloma or chronic lymphocytic
leukemia where they directly modulate IL6-production and/or IL6-R expr
ession.